Washington University, BostonGene Expand Kidney Cancer Research Collaboration

Aug

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Aug

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug

Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

Aug

Featured Webinar

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.

Menu

Washington University, BostonGene Expand Kidney Cancer Research Collaboration

To read the full story....

Breaking News

Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay

PavMed Raises $7M in Private Funding Round

GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer

Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech

IncellDx, Factorial Diagnostics Ink Licensing, Supply Agreement

Becton Dickinson Fiscal Q3 Revenues Drop 11 Percent

Recent Headlines from
Precision Oncology News

Puma's Nerlynx Offers Targeted Treatment Opportunity for HER2-Mutant Cervical Cancer in Basket Trial

Merus, Elevation Oncology Advance Drug Candidates Targeting NRG1 Fusion-Positive Cancers

MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma

My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal Cancer Patients

Researchers Identify Biomarker-Based Strategy to Select Patients for Pancreatic Cancer Surgery

Featured White Papers

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Utility of Novel RNA-Based Tools in Oncology Drug Development

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

What's Popular?

TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers

Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues

Natera's Signatera ctDNA Test Shows Immunotherapy Response Prediction Capability in Advanced Cancer

Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business

Guardant Health Enters CDx Collaboration With Radius Health for Elacestrant in HER2- Breast Cancer

Sponsorships